Clinical Trial Update: Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

View source ↗

Summary

A completed clinical trial evaluating telmisartan alone or in combination with hydrochlorothiazide for mild-to-moderate essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)
• Telmisartan/Hydrochlorothiazide (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED